Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Receives $5.17 Consensus PT from Brokerages
Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average […]
Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average […]
